Baxalta announces secondary offering of common stock owned by Baxter International
Prior to the closing of the offering, Baxter will exchange the shares of Baxalta common stock to be sold in the offering for indebtedness of Baxter currently held by Chase Lincoln First Commercial Corporation (“Chase Lincoln”), an affiliate of the underwriter in the offering. Following the debt-for-equity exchange and offering, Baxter’s retained ownership stake in Baxalta will be reduced from 19.4% to 14.3% (based on the Baxalta closing stock price on January 25, 2016). Chase Lincoln, as selling shareholder, will then sell these shares of Baxalta common stock to the underwriter in connection with the public offering.
J.P. Morgan Securities LLC is acting as the sole underwriter for the offering.
Most read news
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.